As of Oct 27, 2026, OpenEvidence's estimated valuation is $13.69B; its last round was a FF Preferred on Feb 27, 2026, raising $1.72M.
Estimated Valuation$13.69B
Valuation As OfOct 27, 2026
Latest Raise$1.72M
Latest RoundFF Preferred
Latest Funding Valuation-
Latest Funding DateFeb 27, 2026
About OpenEvidence
OpenEvidence is a medical AI company offering an AI-powered clinical search tool that gives doctors evidence-based answers from medical literature at the point of care, often called 'ChatGPT for doctors.'
Funding rounds
| Round | |||
|---|---|---|---|
| Feb 27, 2026 | FF Preferred | $1.72M | - |
| Jan 14, 2026 | Series D | $333.75M | $12B |
| Oct 2, 2025 | Series C-2 | $75M | - |
| Jun 6, 2025 | Series C-1 | $128.04M | $6B |
| May 28, 2025 | Series B-1 | $30M | - |
| May 6, 2025 | Series B | $125M | $3.5B |
| Dec 31, 2024 | Series A | $75M | $1B |
| Jun 7, 2024 | Seed-4 | $5M | - |
| Dec 15, 2023 | Seed-1 | $17.13M | - |
Perpetual markets
No perpetual markets available.
Token issuers
No token issuer markets available.
Frequently asked questions
What is OpenEvidence's estimated valuation?
As of Oct 27, 2026, OpenEvidence's latest tracked valuation estimate is $13.69B.
When was OpenEvidence's last funding round?
OpenEvidence's latest tracked funding round was a FF Preferred on Feb 27, 2026, raising $1.72M.
Valuation and funding data updated Oct 28, 2026, 6:56 AM UTC.
Market data updated Oct 28, 2026, 6:56 AM UTC.